Reference: Weight regain after cessation of medication for weight management: systematic review and meta-analysis by Sam West, Jadine Scragg, Paul Aveyard, Jason L Oke, Lia Willis, Stella J P Haffner, Heather Knight, Danni Wang, Sarah Morrow, Laura Heath, Susan A Jebb and Dimitrios A Koutoukidis, 7 January 2026, BMJ
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects
Synonyms IGF-1 LR3 Long R3 IGF-1 Recombinant IGF-1 Analog Insulin-Like Growth Factor-1 Long Arg3 Research Areas IGF-1 LR3 is utilized in pre-clinical research models across the following areas: Cellular Growth & Proliferation Research: Investigating how IGF-1 receptor activation influences cellular expansion, replication signals, and protein synthesis pathways
Diabetologia 59(7):14121421 Tonneijck L, Muskiet MHA, Smits MM, Hoekstra T, Kramer MHH, Danser AHJ et al (2017) Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: an 8-week, randomised, open-label trial